Navigation Links
'VAP with a Pap' Campaign Targets Women and Heart Disease
Date:2/4/2010

ynecologic examination is often the only routine preventive care they receive," said Steven Foley, M.D. "I first realized the VAP with a Pap was a perfect fit for my practice several years ago and have been using it ever since."

The Colorado Springs, Colo., gynecologist now uses the VAP Test to more accurately assess heart disease risk and to evaluate patients for polycystic ovarian syndrome (PCOS), diabetes and infertility. Foley explained that the VAP Test plays a role in the diagnosis of PCOS because, as an expanded cholesterol test, it measures a range of cholesterol subclasses not measured by the routine cholesterol test.

The VAP Test reports 22 separate components of blood compared to just four in the standard cholesterol test (LDL, HDL, total cholesterol and triglycerides) at no additional cost. This advanced lipid panel does not require fasting and includes a measurement of the patient's Lp(a), an important risk factor much discussed in recent publications, as part of its standard panel.

The American Heart Association recommends cholesterol screening starting at the age of 20. Foley routinely uses the VAP Test on patients over the age of 45 who come in for an annual exam and who have not had a cholesterol test within the past 12 months. He also initially tests all patients one time between the ages of 30-45.

The VAP Test is available nationwide. For more information call 877.901.8510 or visit www.thevaptest.com.

About Atherotech Inc.

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol T
'/>"/>

SOURCE Atherotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Ohio Executive Shares Why Ohio is the Perfect Location for Bioscience Business in National Ad Campaign
2. Biomedical Research Organization Launches Groundbreaking National TV Campaign
3. Nutra Pharmaceutical's U.S. distributor, XenaCare Holdings Announces National Print Advertising Campaign for Cobroxin, a Treatment for Moderate to Severe (Stage 2) Pain
4. avVaa World Health Care Products Inc. Announces Web Site Design for Neuroskin(R) Psoriasis Relief DRTV Campaign
5. avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign
6. Campaign to Increase the Awareness and Understanding of Lou Gehrigs Disease Reaches 22 U.S. States
7. Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
8. Photos: Project Runways Tim Gunn Launches Addressing Psoriasis(TM) Campaign to Advocate That Patients Shouldnt Let Psoriasis Impact Personal Style
9. BioSpace and the Massachusetts Biotechnology Council Inc. Launch 2009 Genetown™ Hotbed Campaign
10. Lilly Contributes $11.1 Million to United Way Annual Campaign
11. Trinity Biotech Investor Group Initiates Campaign of ADR Conversion to Force a Special Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 Invetech ... development, custom automation, and contract manufacturing, and  NanoCellect ... flow cytometry and cell sorting technology for life ... a novel flow cytometry platform. Headquartered ... Biomedical has developed a microchip-based cell sorting technology. ...
(Date:4/21/2015)... , April 21, 2015  scPharmaceuticals, Inc., ... pharmaceutical products for subcutaneous delivery, announced today ... of its investigational proprietary drug product, Furosemide ... associated with congestive heart failure. ... developing a proprietary patch pump.  The patch ...
(Date:4/21/2015)... Cleveleys (UK) (PRWEB) April 21, 2015 ... technology and its clinical applications will be ... Participants include engineers, scientists, regulators and clinicians ... The meeting is sponsored by Invibio Biomaterial ... polymer-based biomaterials, a specialist in manufacturing and ...
(Date:4/20/2015)... and MENLO PARK, Calif. ... Inc. (OTCQX: DMPI) (DelMar and the Company), ... proven cancer therapies in new orphan drug indications, ... 106th Annual Meeting of the American Association for ... potential for its lead product candidate VAL-083 ...
Breaking Biology Technology:NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 2NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 3scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 2scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 32nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 22nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 2DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 5
... will hold the $14 million clinical training programs administrative ... of Wisconsin-Madison intends to train more clinical researchers, whose ... science, with the help of a $14 million, five-year ... , ,Molly Carnes, a professor with appointments in the ...
... UW-Stout gets USDA grant for manufacturing training ETC announces ... in third quarter QRG Bioscience to move to Research ... , Home Health United signs deal with SBC ... a three-year deal with communications firm SBC . SBC will implement ...
... 21st Century Act, commonly called Check 21, two Wisconsin ... imaging. , ,Check 21, which will come into effect ... of the payments system by legalizing the use of ... documents. Using the substitute check, banks are permitted to ...
Cached Biology Technology:$14 million grant to drive clinical research at UW 2Tech Digest: whats moving in the Midwest 2Tech Digest: whats moving in the Midwest 3Wisconsin firms make acquisitions for Check 21 readiness 2
(Date:4/2/2015)... , April 2, 2015 ... tests DERMALOG by far outperforms the strongest competitors, ... maintaining high accuracy, the system is capable of ... the speed proves up to be ten times ... than its runner-up performance.      (Photo: ...
(Date:4/2/2015)... , April 2, 2015 ... Q1 2015 attributed to somewhat higher than 125 MSEK. ... the year-end report 2014 that revenues for Q1 2015 ... the company reported for Q4 2014. The operating result ... be negative. The complete interim report will as previously ...
(Date:4/1/2015)... , Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... Wocket smart wallets is underway to early access pre-order ... group includes usage at retail outlets including Walmart, Target, ... Users report Wocket was accepted at all outlets and ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... are often touted as one method to help decrease society,s addiction ... to be done before fuel cells will be ready for mass ... for emergencies. U of C chemists Jeff Hurd and George ... cell towards a higher level of design. They have discovered a ...
... Scientists are developing new scaffolding technology which could ... and cartilage using 3D spaghetti-like structures. Their research is ... highlights magazine of the Biotechnology and Biological Sciences Research ... by scientists from the University of Bristol, using proteins ...
... clinical-stage biopharmaceutical company developing a new class of drugs ... data from its recently completed Phase 2b clinical trial ... with major depressive disorder, or MDD, who did not ... citalopram hydrobromide. In the trial, the add-on TC-5214 ...
Cached Biology News:U of C chemists discover recipe to design a better type of fuel cell 2'Spaghetti' scaffolding could help grow skin in labs 2Targacept's P.2b depression study succeeds: 6-point difference on HAM-D 2Targacept's P.2b depression study succeeds: 6-point difference on HAM-D 3
... AP Conjugate Stabilizer is an aqueous ... protein and other non-toxic stabilizing chemicals ... pH 5.5 6.5. This ... methylisothiazolone and 0.02% bromonitrodioxane as a ...
MAb to Myoglobin Cardiac...
... binding is a problem in your ... immobilized NeutrAvidin products as superior alternatives ... a modified avidin derivative that combines ... biotin-binding protein with exceptionally low nonspecific ...
Request Info...
Biology Products: